Condition
Fra(X) Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 2 (3)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03862950Phase 2Completed
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
NCT03479476Phase 2Completed
A Trial of Metformin in Individuals With Fragile X Syndrome
NCT03569631Phase 2Completed
A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
NCT04869930Unknown
Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome
Showing all 4 trials